We are live on
!
Find out more
Arax Advisory Partners Portfolio holdings
AUM
$15.1B
Turnover
30.22%
1-Year Est. Return
27.93%
This Fund
S&P 500
This Quarter
Est. Return
+16%
1 Year Est. Return
+27.93%
3 Year Est. Return
+64.69%
5 Year Est. Return
+64.07%
10 Year Est. Return
–
AUM
$15.1B
AUM Growth
+$11.5B
(+326%)
Cap. Flow
+$10.9B
Cap. Flow
% of AUM
71.99%
Top 10 Holdings %
Top 10 Hldgs %
18.25%
Holding
5,282
New
1,518
Increased
3,295
Reduced
222
Closed
78
Avg Time Held Equity + Options
1.4
years
Top 10 Avg Time Held Equity + Options
0.6
years
Top 20 Avg Time Held Equity + Options
0.8
years
Avg Time Held Equity only
1.4
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$331M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$324M |
| 3 |
NVIDIA
NVDA
|
+$260M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$219M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares High Yield Muni Active ETF
HIMU
|
+$4.53M |
| 2 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$3.23M |
| 3 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$2.25M |
| 4 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$2.21M |
| 5 |
Capital Group Growth ETF
CGGR
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.68% |
| 2 | Technology | 13.1% |
| 3 | Industrials | 6.81% |
| 4 | Financials | 6.59% |
| 5 | Energy | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5151
iShares Mortgage Real Estate ETF
REM
$452M
| $67 | ﹤0.01% |
3
+1
| +50% | +$22 |
2025 Q4
2 quarters
|
|
5152
Public Policy Holding Co
PPHC
$309M
| $66 | ﹤0.01% |
+9
| New | +$106 |
2026 Q2
0 quarters
|
|
5153
Achieve Life Sciences
ACHV
$650M
| $65 | ﹤0.01% |
10
+9
| +900% | +$43 |
2025 Q3
3 quarters
|
|
5154
AXS Astoria Inflation Sensitive ETF
PPI
$157M
| $64 | ﹤0.01% |
+3
| New | +$65 |
2026 Q2
0 quarters
|
|
5155
Mannatech
MTEX
$13.6M
| $63 | ﹤0.01% |
12
| – | – |
2025 Q1
5 quarters
|
|
5156
QuickLogic
QUIK
$168M
| $60 | ﹤0.01% |
3
| – | – |
2025 Q3
3 quarters
|
|
5157
Virgin Galactic
SPCE
$373M
| $59 | ﹤0.01% |
20
+18
| +900% | +$59 |
2025 Q1
5 quarters
|
|
5158
Babcock & Wilcox
BW
$694M
| $56 | ﹤0.01% |
+4
| New | +$68 |
2026 Q2
0 quarters
|
|
5159
DiaMedica Therapeutics
DMAC
$418M
| $56 | ﹤0.01% |
+8
| New | +$49 |
2026 Q2
0 quarters
|
|
5160
CMB.TECH NV
CMBT
$5.04B
| $56 | ﹤0.01% |
4
-30
| -88% | -$432 |
2025 Q3
3 quarters
|
|
5161
CervoMed
CRVO
$34.5M
| $53 | ﹤0.01% |
17
+3
| +21% | +$11 |
2025 Q3
3 quarters
|
|
5162
Invesco DB Agriculture Fund
DBA
$1.22B
| $53 | ﹤0.01% |
+2
| New | +$55 |
2026 Q2
0 quarters
|
|
5163
Citius Pharmaceuticals
CTXR
$12.6M
| $51 | ﹤0.01% |
+84
| New | +$57 |
2026 Q2
0 quarters
|
|
5164
Bonk Inc
BNKK
$9.52M
| $51 | ﹤0.01% |
33
-26
| -44% | -$56 |
2025 Q3
3 quarters
|
|
5165
Everspin Technologies
MRAM
$320M
| $48 | ﹤0.01% |
2
-20
| -91% | -$448 |
2025 Q3
3 quarters
|
|
5166
Pyxis Oncology
PYXS
$139M
| $42 | ﹤0.01% |
14
+13
| +1,300% | +$25 |
2025 Q3
3 quarters
|
|
5167
XCF Global Inc
SAFX
$64.7M
| $42 | ﹤0.01% |
95
+68
| +252% | +$31 |
2026 Q1
1 quarter
|
|
5168
Knightscope
KSCP
$13.1M
| $38 | ﹤0.01% |
+18
| New | +$51 |
2026 Q2
0 quarters
|
|
|
SMTK
5169
SmartKem
SMTK
$549K
| $36 | ﹤0.01% |
+3
| New | +$45 |
2026 Q2
0 quarters
|
|
5170
Cabaletta Bio
CABA
$239M
| $31 | ﹤0.01% |
10
+8
| +400% | +$26 |
2025 Q3
3 quarters
|
|
5171
Gen Digital Inc Contingent Value Rights
GENVR
| $31 | ﹤0.01% |
24
+19
| +380% | +$20 |
2025 Q4
2 quarters
|
|
5172
reAlpha
AIRE
$5.95M
| $28 | ﹤0.01% |
+14
| New | +$51 |
2026 Q2
0 quarters
|
|
5173
Corbus Pharmaceuticals
CRBP
$90.1M
| $28 | ﹤0.01% |
3
| – | – |
2025 Q3
3 quarters
|
|
5174
Trilogy Metals
TMQ
$430M
| $28 | ﹤0.01% |
+8
| New | +$33 |
2026 Q2
0 quarters
|
|
5175
DeFi Development Corp Warrant
DFDVW
$1.64M
| $28 | ﹤0.01% |
+102
| New | +$50 |
2026 Q2
0 quarters
|
|
Similar funds
Arax Advisory Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Arax Advisory Partners held 5,282 positions worth $15.1B, up 326% from $3.54B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arax Advisory Partners deployed $10.9B of net new capital in Q2 2026, opening 1,518 new positions and adding to 3,295 existing holdings. Its largest new stake was ClearShares Piton Intermediate Fixed Income ETF: 984,286 shares worth $92M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 70% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iShares High Yield Muni Active ETF, an estimated $4.53M trimmed.
- Arax Advisory Partners's largest Q2 2026 buy was ClearShares Piton Intermediate Fixed Income ETF: 984,286 shares worth $92M.
- Arax Advisory Partners added most to Apple in Q2 2026, an estimated $331M increase.
- Arax Advisory Partners's biggest Q2 2026 reduction was iShares High Yield Muni Active ETF, cutting an estimated $4.53M.
- Arax Advisory Partners fully exited Monroe Capital Corp in Q2 2026, selling an estimated $379K.
- Arax Advisory Partners's ten largest holdings make up 18% of its $15.1B portfolio in Q2 2026.
- Arax Advisory Partners opened 1,518 new positions and closed 78 in Q2 2026.
- Arax Advisory Partners's portfolio value rose 326% quarter-over-quarter to $15.1B.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.